CN111088225B - Method for promoting directional differentiation of mesenchymal stem cells - Google Patents
Method for promoting directional differentiation of mesenchymal stem cells Download PDFInfo
- Publication number
- CN111088225B CN111088225B CN202010210967.8A CN202010210967A CN111088225B CN 111088225 B CN111088225 B CN 111088225B CN 202010210967 A CN202010210967 A CN 202010210967A CN 111088225 B CN111088225 B CN 111088225B
- Authority
- CN
- China
- Prior art keywords
- mass
- parts
- stem cells
- differentiation
- mesenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
- C01B32/158—Carbon nanotubes
- C01B32/168—After-treatment
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/06—Ferric oxide (Fe2O3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/305—Growth hormone [GH], aka. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
Abstract
The invention relates to the field of stem cells, and provides a method for promoting directional differentiation of mesenchymal stem cells, which is used for solving the problem of low differentiation efficiency of the stem cells to osteocytes. The invention provides a method for promoting directional differentiation of mesenchymal stem cells, which comprises the following steps: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation medium comprises: 3-5 mu g/ml of insulin, 0.05-0.08 mu g/ml of transferrin, 1-3 ng/ml of growth hormone, 80-100 mu g/ml of glutathione, 0.5-2 mM of L-glutamine, 20-50 mu M of beta-mercaptoethanol, 0.5-0.7 mM of sodium pyruvate, 0.05-0.1 mM of unnecessary amino acid, 8-12 mu M of nano ferric oxide and the balance of DMEM culture medium. Biological serum is not added into the culture medium, and the nano oxide is introduced, so that the differentiation of the mesenchymal stem cells to bone cells can be remarkably promoted.
Description
Technical Field
The invention relates to the field of stem cells, in particular to a method for promoting directional differentiation of mesenchymal stem cells.
Background
Stem cells are a cell type with self-renewal capacity and multi-differentiation potential, and are the first cells in a series of processes from proliferation, migration, differentiation and maturation of human neonatal cells. Research on stem cells has become one of the most biologically challenging and attractive areas today. Stem cells are classified into embryonic stem cells and adult stem cells according to their source. Mesenchymal Stem Cells (MSCs) are one of the adult stem cells. Mesenchymal stem cells, a class of adult stem cells with self-renewal capacity, can differentiate into a variety of cell tissue types. It can differentiate not only into a variety of mesenchymal-derived cell lineages, such as adipocytes, osteoblasts, chondrocytes, myoblasts, etc., but also into other cell lineages, such as astrocytes, myoblasts, cardiomyocytes, and nerve cells, etc. Since MSCs isolated and cultured in vitro have no obvious change in cell phenotype and no loss of function, they are considered to be of great significance for cell therapy and tissue repair engineering.
How to promote the directional differentiation of the mesenchymal stem cells is a problem to be solved urgently.
Disclosure of Invention
The invention provides a method for promoting directional differentiation of mesenchymal stem cells, aiming at solving the problem of low differentiation efficiency of stem cells to osteocytes.
In order to solve the technical problems, the technical scheme provided by the invention is as follows:
a method of promoting directed differentiation of mesenchymal stem cells, comprising: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation medium comprises: 3-5 mu g/ml of insulin, 0.05-0.08 mu g/ml of transferrin, 1-3 ng/ml of growth hormone, 80-100 mu g/ml of glutathione, 0.5-2 mM of L-glutamine, 20-50 mu M of beta-mercaptoethanol, 0.5-0.7 mM of sodium pyruvate, 0.05-0.1 mM of unnecessary amino acid, 8-12 mu M of nano ferric oxide and the balance of DMEM culture medium.
The nano ferric oxide is introduced into the culture medium of the stem cells, so that the differentiation of the stem cells to the bone cells can be promoted to a certain extent.
Biological serum is not added into the culture medium, and the nano oxide is introduced, so that the differentiation of the mesenchymal stem cells to bone cells can be remarkably promoted.
Preferably, the culture medium comprises 4-5 mu g/ml of insulin, 0.06-0.08 mu g/ml of transferrin, 2-3 ng/ml of growth hormone, 90-100 mu g/ml of glutathione, 1.5-2 mM of L-glutamine, 25-50 mu M of beta-mercaptoethanol, 0.6-0.7 mM of sodium pyruvate, 0.08-0.1 mM of unnecessary amino acid, 10-12 mu M of nano ferric oxide and the balance of DMEM culture medium.
Preferably, the composition comprises 4 mu g/ml of insulin, 0.06 mu g/ml of transferrin, 2ng/ml of growth hormone, 90 mu g/ml of glutathione, 1.5mM of L-glutamine, 25 mu M of beta-mercaptoethanol, 0.6mM of sodium pyruvate, 0.08mM of non-essential amino acid, 10 mu M of nano ferric oxide and the balance of DMEM culture medium.
Preferably, the nano ferric oxide is modified nano ferric oxide. The modified ferric oxide can further promote the differentiation of stem cells to osteocytes.
Preferably, the preparation method of the modified ferric oxide comprises the following steps: taking 20-25 parts by mass of ferric nitrate, 1-3 parts by mass of silver nitrate, 15-20 parts by mass of sodium hydroxide and 3-5 parts by mass of carbon nano tubes; dissolving ferric nitrate in 40 times of absolute ethyl alcohol, dissolving silver nitrate in 50 times of deionized water, and mixing the aqueous solution of the silver nitrate with the ethanol solution of the ferric nitrate to obtain a mixed solution; dissolving sodium hydroxide in 5 times of deionized water to obtain a sodium hydroxide solution, mixing the sodium hydroxide solution with the mixed solution, stirring, performing ultrasonic treatment for 20min, heating to 150 ℃, performing heat preservation reaction for 12h, taking a product, washing the product with deionized water and absolute ethyl alcohol for multiple times, drying, and sintering at 600-800 ℃ for 2h to obtain powder; ball-milling the powder and the carbon nano tube for 2 hours, adding deionized water in the ball-milling process to obtain slurry, drying the slurry to obtain a dried product, and calcining the product at 400-600 ℃ to obtain the modified ferric oxide. The carbon nano tube is added to modify the nano ferric oxide, so that the differentiation of the stem cells to the bone cells can be further promoted.
Preferably, the carbon nano tube coating comprises 21-25 parts by mass of ferric nitrate, 2-3 parts by mass of silver nitrate, 17-20 parts by mass of sodium hydroxide and 4-5 parts by mass of carbon nano tubes.
Preferably, the carbon nano tube comprises 21 parts by mass of ferric nitrate, 2 parts by mass of silver nitrate, 17 parts by mass of sodium hydroxide and 4 parts by mass of carbon nano tubes.
Preferably, the carbon nanotube is a modified carbon nanotube, and the modification method of the carbon nanotube is as follows; taking 1-2 parts by mass of a carbon nano tube, 200-400 parts by mass of dimethylformamide and 5-10 parts by mass of zinc acetate; ablating the carbon nano tube for 3 hours at 500-600 ℃, carrying out reflux acid washing on the carbon nano tube by using nitric acid after ablation, and then washing the carbon nano tube by using deionized water until filtrate is neutral; dispersing the ablated carbon nano tube into dimethylformamide, carrying out ultrasonic treatment for 1 hour, then stirring, slowly adding zinc acetate in a stirring state, carrying out ultrasonic treatment for 2 hours again, transferring the obtained solution into a hydrothermal reaction kettle, adding the solution into the hydrothermal reaction kettle for 10-15 hours, and heating the solution at the temperature of 60-90 ℃ to obtain a product; and alternately washing the obtained product with ethanol and deionized water for 5-8 times to obtain the modified carbon nanotube. The nano ferric oxide is modified by the modified carbon nano tube, so that the nano ferric oxide can better promote the differentiation of stem cells to osteocytes.
Preferably, the carbon nano tube comprises 1.5-2 parts by mass of dimethylformamide and 8-10 parts by mass of zinc acetate.
Preferably, the carbon nano tube comprises 1.5 parts by mass, 300 parts by mass of dimethylformamide and 8 parts by mass of zinc acetate.
Compared with the prior art, the invention has the beneficial effects that: biological serum is not added into the culture medium, and the carbon nano tube is introduced, so that the differentiation of the mesenchymal stem cells to bone cells can be remarkably promoted; can greatly improve the osteogenic differentiation efficiency of stem cells.
Detailed Description
The following examples are further illustrative of the present invention and are not intended to be limiting thereof.
Example 1
A method of promoting directed differentiation of mesenchymal stem cells, comprising: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation culture medium comprises 4 mu g/ml of insulin, 0.06 mu g/ml of transferrin, 2ng/ml of growth hormone, 90 mu g/ml of glutathione, 1.5mM of L-glutamine, 25 mu M of beta-mercaptoethanol, 0.6mM of sodium pyruvate, 0.08mM of non-essential amino acid, 10 mu M of nano ferric oxide and the balance of DMEM culture medium. The nano ferric oxide is modified nano ferric oxide. The preparation method of the modified ferric oxide comprises the following steps: taking 21 parts by mass of ferric nitrate, 2 parts by mass of silver nitrate, 17 parts by mass of sodium hydroxide and 4 parts by mass of carbon nano tubes; dissolving ferric nitrate in 40 times of absolute ethyl alcohol, dissolving silver nitrate in 50 times of deionized water, and mixing the aqueous solution of the silver nitrate with the ethanol solution of the ferric nitrate to obtain a mixed solution; dissolving sodium hydroxide in 5 times of deionized water to obtain a sodium hydroxide solution, mixing the sodium hydroxide solution with the mixed solution, stirring, performing ultrasonic treatment for 20min, heating to 150 ℃, performing heat preservation reaction for 12h, taking a product, washing the product with deionized water and absolute ethyl alcohol for multiple times, drying, and sintering at 700 ℃ for 2h to obtain powder; ball-milling the powder and the carbon nano tube for 2 hours, adding deionized water in the ball-milling process to obtain slurry, drying the slurry to obtain a dried product, and calcining the product at 500 ℃ to obtain the modified ferric oxide. The carbon nano tube is a modified carbon nano tube, and the modification method of the carbon nano tube comprises the following steps: taking 1.5 parts by mass of a carbon nano tube, 300 parts by mass of dimethylformamide and 8 parts by mass of zinc acetate; ablating the carbon nano tube at 550 ℃ for 3h, carrying out reflux acid washing by using nitric acid after ablation, and then washing by using deionized water until the filtrate is neutral; dispersing the ablated carbon nano tube into dimethylformamide, carrying out ultrasonic treatment for 1 hour, then stirring, slowly adding zinc acetate under the stirring state, carrying out ultrasonic treatment for 2 hours again, transferring the obtained solution into a hydrothermal reaction kettle, adding the solution for 12 hours, and heating at 80 ℃ to obtain a product; and washing the obtained product with ethanol and deionized water alternately for 6 times to obtain the modified carbon nanotube.
The nano ferric oxide is introduced into the culture medium of the stem cells, so that the differentiation of the stem cells to the bone cells can be promoted to a certain extent. Biological serum is not added into the culture medium, and the nano oxide is introduced, so that the differentiation of the mesenchymal stem cells to bone cells can be remarkably promoted. The modified ferric oxide can further promote the differentiation of stem cells to osteocytes. The carbon nano tube is added to modify the nano ferric oxide, so that the differentiation of the stem cells to the bone cells can be further promoted. The nano ferric oxide is modified by the modified carbon nano tube, so that the nano ferric oxide can better promote the differentiation of stem cells to osteocytes.
Example 2
A method of promoting directed differentiation of mesenchymal stem cells, comprising: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation medium comprises: 3 mu g/ml of insulin, 0.05 mu g/ml of transferrin, 1ng/ml of growth hormone, 80 mu g/ml of glutathione, 0.5mM of L-glutamine, 20 mu M of beta-mercaptoethanol, 0.5mM of sodium pyruvate, 0.05mM of non-essential amino acid, 8 mu M of nano ferric oxide and the balance of DMEM medium. The nano ferric oxide is modified nano ferric oxide. The preparation method of the modified ferric oxide comprises the following steps: taking 20 parts by mass of ferric nitrate, 1 part by mass of silver nitrate, 15 parts by mass of sodium hydroxide and 3 parts by mass of carbon nano tubes; dissolving ferric nitrate in 40 times of absolute ethyl alcohol, dissolving silver nitrate in 50 times of deionized water, and mixing the aqueous solution of the silver nitrate with the ethanol solution of the ferric nitrate to obtain a mixed solution; dissolving sodium hydroxide in 5 times of deionized water to obtain a sodium hydroxide solution, mixing the sodium hydroxide solution with the mixed solution, stirring, performing ultrasonic treatment for 20min, heating to 150 ℃, performing heat preservation reaction for 12h, taking a product, washing the product with deionized water and absolute ethyl alcohol for multiple times, drying, and sintering at 600 ℃ for 2h to obtain powder; ball-milling the powder and the carbon nano tube for 2 hours, adding deionized water in the ball-milling process to obtain slurry, drying the slurry to obtain a dried product, and calcining the product at 400 ℃ to obtain the modified ferric oxide. The carbon nano tube is a modified carbon nano tube, and the modification method of the carbon nano tube comprises the following steps: taking 1 part by mass of a carbon nano tube, 200 parts by mass of dimethylformamide and 5 parts by mass of zinc acetate; ablating the carbon nano tube at 500 ℃ for 3h, carrying out reflux acid washing by using nitric acid after ablation, and then washing by using deionized water until the filtrate is neutral; dispersing the ablated carbon nano tube into dimethylformamide, carrying out ultrasonic treatment for 1 hour, then stirring, slowly adding zinc acetate under the stirring state, carrying out ultrasonic treatment for 2 hours again, transferring the obtained solution into a hydrothermal reaction kettle, adding the solution into the hydrothermal reaction kettle for 10 hours, and heating the solution at the temperature of 60 ℃ to obtain a product; and washing the obtained product with ethanol and deionized water for 5 times alternately to obtain the modified carbon nanotube.
Example 3
A method of promoting directed differentiation of mesenchymal stem cells, comprising: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation medium comprises: 5 mu g/ml of insulin, 0.08 mu g/ml of transferrin, 3ng/ml of growth hormone, 100 mu g/ml of glutathione, 2mM of L-glutamine, 50 mu M of beta-mercaptoethanol, 0.7mM of sodium pyruvate, 0.1mM of non-essential amino acid, 12 mu M of nano ferric oxide and the balance of DMEM culture medium. The nano ferric oxide is modified nano ferric oxide. The preparation method of the modified ferric oxide comprises the following steps: taking 25 parts by mass of ferric nitrate, 3 parts by mass of silver nitrate, 20 parts by mass of sodium hydroxide and 5 parts by mass of carbon nano tubes; dissolving ferric nitrate in 40 times of absolute ethyl alcohol, dissolving silver nitrate in 50 times of deionized water, and mixing the aqueous solution of the silver nitrate with the ethanol solution of the ferric nitrate to obtain a mixed solution; dissolving sodium hydroxide in 5 times of deionized water to obtain a sodium hydroxide solution, mixing the sodium hydroxide solution with the mixed solution, stirring, performing ultrasonic treatment for 20min, heating to 150 ℃, performing heat preservation reaction for 12h, taking a product, washing the product with deionized water and absolute ethyl alcohol for multiple times, drying, and sintering at 800 ℃ for 2h to obtain powder; ball-milling the powder and the carbon nano tube for 2 hours, adding deionized water in the ball-milling process to obtain slurry, drying the slurry to obtain a dried product, and calcining the product at 600 ℃ to obtain the modified ferric oxide. The carbon nano tube is a modified carbon nano tube, and the modification method of the carbon nano tube comprises the following steps: taking 2 parts by mass of a carbon nano tube, 400 parts by mass of dimethylformamide and 10 parts by mass of zinc acetate; ablating the carbon nano tube for 3 hours at 600 ℃, carrying out reflux acid washing by using nitric acid after ablation, and then washing by using deionized water until the filtrate is neutral; dispersing the ablated carbon nano tube into dimethyl formamide, carrying out ultrasonic treatment for 1h, then stirring, slowly adding zinc acetate in a stirring state, carrying out ultrasonic treatment for 2h again, transferring the obtained solution into a hydrothermal reaction kettle, adding the solution for 15h, and heating at 90 ℃ to obtain a product; and washing the obtained product with ethanol and deionized water for 8 times alternately to obtain the modified carbon nanotube.
Example 4
Example 4 is different from example 1 in that the nano ferric oxide is not modified, and the nano ferric oxide is commercially available nano ferric oxide.
Example 5
Example 5 differs from example 1 in that the carbon nanotubes are not modified.
Example 6
The embodiment 6 is different from the embodiment 1 in that the modification method of the nano ferric oxide comprises the following steps: and dispersing the nano ferric oxide and the carbon nano tube into deionized water together, performing ultrasonic treatment for 1h, drying and roasting to obtain the modified nano ferric oxide.
Comparative example 1
Comparative example 1 differs from example 1 in that it comprises 4. mu.g/ml of insulin, 0.06. mu.g/ml of transferrin, 2ng/ml of growth hormone, 90. mu.g/ml of glutathione, 1.5mM of L-glutamine, 25. mu.M of beta-mercaptoethanol, 0.6mM of sodium pyruvate, 0.08mM of an optional amino acid, and the balance of DMEM medium.
Comparative example 2
Comparative example 2 differs from example 1 in that it comprises: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation medium comprises: 2 mu g/ml of insulin, 0.03 mu g/ml of transferrin, 0.5ng/ml of growth hormone, 60 mu g/ml of glutathione, 0.2mM of L-glutamine, 15 mu M of beta-mercaptoethanol, 0.3mM of sodium pyruvate, 0.02mM of non-essential amino acid, 5 mu M of nano ferric oxide and the balance of DMEM culture medium.
Comparative example 3
Comparative example 3 differs from example 1 in that it comprises: culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage; inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture; the differentiation medium comprises: 10 mu g/ml of insulin, 0.1 mu g/ml of transferrin, 5ng/ml of growth hormone, 120 mu g/ml of glutathione, 3mM of L-glutamine, 60 mu M of beta-mercaptoethanol, 0.8mM of sodium pyruvate, 0.2mM of non-essential amino acid, 15 mu M of nano ferric oxide and the balance of DMEM culture medium.
Examples of the experiments
Calcium deposition of the extracellular matrix is dyed by 0.5% alizarin red liquid for 1 hour, washed by PBS and incubated by 500ul1% hydrogen chloride, and a light absorption value is detected at 420nm by a multifunctional microplate reader to analyze the result of calcium deposition amount of the osteogenic differentiation extracellular matrix, so that the effect of the culture medium on achievement differentiation is analyzed. As shown in table 1.
TABLE 1 osteogenic differentiation Rate
In examples 1 to 6, on the basis of comparative example 1, the proliferation rate is increased by 11.5 to 98.5%, which indicates that the introduction of nano ferric oxide into the culture medium can significantly improve the differentiation efficiency of stem cells and provide conditions for large-scale osteogenic differentiation of stem cells.
The stem cell differentiation effect in examples 1 to 3 is relatively remarkable, which indicates that the nano ferric oxide treated by the modified carbon nanotube can effectively promote the stem cell differentiation, and the stem cell differentiation effect of example 1 is obviously superior to that of examples 2 and 3, which indicates that the stem cell differentiation rate can be further improved by adding a certain amount of nano ferric oxide.
The differentiation rate of the nano ferric oxide in the embodiment 4 is not modified, but the improvement effect is weaker than that of the embodiment 1-3, which shows that the modified ferric oxide can further improve the differentiation rate of the stem cells.
In the embodiment 5, the effect of compounding unmodified carbon nanotubes and nano ferric oxide is weaker than that of the embodiment 1; the modification method of nano-ferric oxide in example 6 is different from that of example 1, and the effect is weaker than that of example 1, which shows that only nano-ferric oxide treated by carbon nanotubes modified by a certain method can promote the differentiation of stem cells into osteocytes.
The comparative example 1 is not added with the nano ferric oxide, the addition amount of the nano ferric oxide in the comparative examples 2 and 3 is greatly different from that in the examples 1-3, and the effect of the comparative examples 2 and 3 on promoting the proliferation of the stem cells is not obviously changed compared with the comparative example 1, which shows that only a certain addition amount of the nano ferric oxide can promote the differentiation of the stem cells.
The above detailed description is specific to possible embodiments of the present invention, and the above embodiments are not intended to limit the scope of the present invention, and all equivalent implementations or modifications that do not depart from the scope of the present invention should be included in the present claims.
Claims (7)
1. A method of promoting osteogenic differentiation of mesenchymal stem cells, comprising:
culturing mesenchymal stem cells by adopting a DMEM culture medium, recovering the cells, carrying out adherent culture in a 6-well plate, digesting by using 0.25% pancreatin every 2 days, and carrying out passage;
inoculating the mesenchymal stem cells obtained by culture to a differentiation culture medium for induced differentiation culture;
the differentiation medium comprises: 3-5 mu g/ml of insulin, 0.05-0.08 mu g/ml of transferrin, 1-3 ng/ml of growth hormone, 80-100 mu g/ml of glutathione, 0.5-2 mM of L-glutamine, 20-50 mu M of beta-mercaptoethanol, 0.5-0.7 mM of sodium pyruvate, 0.05-0.1 mM of non-essential amino acid, 8-12 mu M of nano ferric oxide and the balance of DMEM culture medium;
the preparation method of the nano ferric oxide comprises the following steps:
taking 20-25 parts by mass of ferric nitrate, 1-3 parts by mass of silver nitrate, 15-20 parts by mass of sodium hydroxide and 3-5 parts by mass of modified carbon nanotubes;
dissolving ferric nitrate in 40 times of absolute ethyl alcohol, dissolving silver nitrate in 50 times of deionized water, and mixing the aqueous solution of the silver nitrate with the ethanol solution of the ferric nitrate to obtain a mixed solution; dissolving sodium hydroxide in 5 times of deionized water to obtain a sodium hydroxide solution, mixing the sodium hydroxide solution with the mixed solution, stirring, performing ultrasonic treatment for 20min, heating to 150 ℃, performing heat preservation reaction for 12h, taking a product, washing the product with deionized water and absolute ethyl alcohol for multiple times, drying, and sintering at 600-800 ℃ for 2h to obtain powder;
ball-milling the powder and the modified carbon nano tube for 2 hours, adding deionized water in the ball-milling process to obtain slurry, drying the slurry to obtain a dried product, and calcining the product at 400-600 ℃ to obtain nano ferric oxide;
the modification method of the modified carbon nano tube comprises the following steps:
taking 1-2 parts by mass of a carbon nano tube, 200-400 parts by mass of dimethylformamide and 5-10 parts by mass of zinc acetate;
ablating the carbon nano tube for 3 hours at 500-600 ℃, carrying out reflux acid washing on the carbon nano tube by using nitric acid after ablation, and then washing the carbon nano tube by using deionized water until filtrate is neutral;
dispersing the ablated carbon nano tube into dimethylformamide, carrying out ultrasonic treatment for 1 hour, then stirring, slowly adding zinc acetate in a stirring state, carrying out ultrasonic treatment for 2 hours again, transferring the obtained solution into a hydrothermal reaction kettle, adding the solution into the hydrothermal reaction kettle for 10-15 hours, and heating the solution at the temperature of 60-90 ℃ to obtain a product;
and alternately washing the obtained product with ethanol and deionized water for 5-8 times to obtain the modified carbon nanotube.
2. The method for promoting osteogenic differentiation of mesenchymal stem cells according to claim 1, wherein the differentiation medium comprises 4-5 μ g/ml of insulin, 0.06-0.08 μ g/ml of transferrin, 2-3 ng/ml of growth hormone, 90-100 μ g/ml of glutathione, 1.5-2 mM of L-glutamine, 25-50 μ M of beta-mercaptoethanol, 0.6-0.7 mM of sodium pyruvate, 0.08-0.1 mM of non-essential amino acids, 10-12 μ M of nano ferric oxide, and the balance being DMEM medium.
3. The method for promoting osteogenic differentiation of mesenchymal stem cells according to claim 2, wherein the differentiation medium comprises insulin 4 μ g/ml, transferrin 0.06 μ g/ml, growth hormone 2ng/ml, glutathione 90 μ g/ml, L-glutamine 1.5mM, β -mercaptoethanol 25 μ M, sodium pyruvate 0.6mM, non-essential amino acids 0.08mM, nano iron sesquioxide 10 μ M, and the balance DMEM medium.
4. A method for promoting osteogenic differentiation of mesenchymal stem cells according to claim 1, wherein the modified carbon nanotubes comprise 21 to 25 parts by mass of ferric nitrate, 2 to 3 parts by mass of silver nitrate, 17 to 20 parts by mass of sodium hydroxide, and 4 to 5 parts by mass of modified carbon nanotubes.
5. A method for promoting osteogenic differentiation of mesenchymal stem cells according to claim 4, wherein the modified carbon nanotubes are prepared from 21 parts by mass of ferric nitrate, 2 parts by mass of silver nitrate, 17 parts by mass of sodium hydroxide and 4 parts by mass of modified carbon nanotubes.
6. A method for promoting osteogenic differentiation of mesenchymal stem cells according to claim 1, wherein the carbon nanotubes are selected from the group consisting of 1.5 to 2 parts by mass of carbon nanotubes, 300 to 400 parts by mass of dimethylformamide, and 8 to 10 parts by mass of zinc acetate.
7. A method for promoting osteogenic differentiation of mesenchymal stem cells according to claim 6, wherein 1.5 parts by mass of carbon nanotubes, 300 parts by mass of dimethylformamide and 8 parts by mass of zinc acetate are taken.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010210967.8A CN111088225B (en) | 2020-03-24 | 2020-03-24 | Method for promoting directional differentiation of mesenchymal stem cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010210967.8A CN111088225B (en) | 2020-03-24 | 2020-03-24 | Method for promoting directional differentiation of mesenchymal stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111088225A CN111088225A (en) | 2020-05-01 |
| CN111088225B true CN111088225B (en) | 2020-09-01 |
Family
ID=70400668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010210967.8A Active CN111088225B (en) | 2020-03-24 | 2020-03-24 | Method for promoting directional differentiation of mesenchymal stem cells |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111088225B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111808814B (en) * | 2020-09-03 | 2021-01-08 | 朗姿赛尔生物科技（广州）有限公司 | Method for promoting proliferation of neural stem cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102157358B (en) * | 2010-12-30 | 2012-08-29 | 北京理工大学 | Method for synthesizing carbon nano tube and zinc oxide heterostructure by hydrothermal method |
| KR101350825B1 (en) * | 2012-01-17 | 2014-01-16 | 서울대학교산학협력단 | Method for producing carbonnanotube substrate for regulation of the growth and differentiation of stem cell |
| CN102583315A (en) * | 2012-02-15 | 2012-07-18 | 西北工业大学 | Method for preparing ferroferric oxide/ carbon nano tube composite material |
| CN104099295B (en) * | 2014-07-07 | 2016-08-31 | 暨南大学 | Magnetic Nano material application in promoting mescenchymal stem cell Osteoblast Differentiation |
| KR101952761B1 (en) * | 2016-12-09 | 2019-05-20 | 강원대학교산학협력단 | A Method for Inducing Enhanced Adhesions and Osteogenesis on Mesenchymal Stem cells using magnetic field |
| CN107144615B (en) * | 2017-07-06 | 2019-03-15 | 吉林大学 | Mix the formaldehyde gas sensor and preparation method thereof of silver-colored ferric oxide nano-material |
| CN109745341B (en) * | 2019-01-25 | 2021-06-08 | 中国医学科学院北京协和医院 | Ferroferric oxide superparamagnetic nanoparticle stimulation stem cell exosome osteogenesis |
-
2020
- 2020-03-24 CN CN202010210967.8A patent/CN111088225B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN111088225A (en) | 2020-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111073850B (en) | Culture medium for promoting mesenchymal stem cell differentiation | |
| CN111088225B (en) | Method for promoting directional differentiation of mesenchymal stem cells | |
| CN107254442A (en) | A kind of artificial induction's pluripotent stem cell differentiation is the method for neural precursor | |
| CN105039248A (en) | Tree shrew mesenchymal stem cells culture system | |
| CN107022515A (en) | One plant of genetic engineering bacterium and its construction method and application using ligno-cellulose hydrolysate anaerobic fermentation production L aspartic acids | |
| CN102690841A (en) | Genetic transformation method for acquiring Taxus chinensis transgenic callus | |
| CN110218736B (en) | Transformation method for improving AcdS production capacity of PGPR | |
| CN104212820A (en) | Enzyme with catalase activity and encoding gene of enzyme | |
| CN114164190B (en) | Fusion enzyme for producing nicotinamide mononucleotide and application thereof | |
| CN111763655B (en) | Method for promoting stem cell expansion | |
| JP2023133181A (en) | Production methods of recombinant escherichia coli and high purity ursodeoxycholic acid | |
| CN109022406A (en) | It is a kind of with the algin catenase AlgA1 of acclimatization to cold characteristic and its application | |
| CN109022404A (en) | A kind of novel Cold tolerance algin catenase AlgA7 and its application | |
| WO2021104360A1 (en) | Method for improving efficiency of in vitro suspension culture of human multifunctional stem cells | |
| CN104946586A (en) | Pretreatment method of mesenchymal stem cells and preparation obtained from mesenchymal stem cells | |
| CN107287160A (en) | A kind of artificial induction's pluripotent stem cell differentiation is the method for nerve cell | |
| CN107326006B (en) | A kind of human embryo stem cell is divided into the dedicated culture medium of endothelial cell and its method | |
| TWI432577B (en) | Method for controlling attachment of cells | |
| CN111019859A (en) | Application of L-arginine as chemotactic substance and mass swimming substance of bacillus cereus | |
| CN106957814B (en) | Culture medium for amniotic mesenchymal stem cells and method for culturing amniotic mesenchymal stem cells | |
| CN108588062A (en) | A kind of method and its application obtaining mutant of trehalose synthetase | |
| Yihao et al. | Correlation between cancer cell stemness and glucose metabolism characteristics in hepatocellular carcinoma | |
| CN111378615A (en) | Culture medium for promoting osteogenic differentiation of mesenchymal stem cells | |
| CN116511516B (en) | Novel copper-based nano material and application thereof in antioxidation and bacteriostasis | |
| CN111334464A (en) | Application of goose paramyxovirus in accelerating proliferation rate of goose fibroblasts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: Building F2, 39 Ruihe Road, Huangpu District, Guangzhou City, Guangdong Province 510000 Patentee after: Lancy Purcell Biotechnology (Guangzhou) Co.,Ltd. Address before: 510000 Room D09, 4th Floor, 131 Airport Road, Baiyun District, Guangzhou City, Guangdong Province Patentee before: Lancy Purcell Biotechnology (Guangzhou) Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Method for Promoting Directional Differentiation of Mesenchymal Stem Cells Effective date of registration: 20230629 Granted publication date: 20200901 Pledgee: Hunan Pingjiang Rural Commercial Bank Co.,Ltd. Pledgor: Chen Zhongping|Lancy Purcell Biotechnology (Guangzhou) Co.,Ltd. Registration number: Y2023980046730 |